p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells

Molecular and Cellular Biology

Volumn 16, Issue 9, 1996, Pages 5178-5185

  Eizenberg, Orly ^a   Faber Elman, Anat ^a   Gottlieb, Eyal ^a   Oren, Moshe ^a   Rotter, Varda ^a   Schwartz, Michal ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; DIAGNOSIS; ETIOLOGY; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; REGULATOR GENE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0029767029     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.9.5178     Document Type: Article

References (82)

1. Allcutt, D., M. Berry, and J. Sievers. 1984. A qualitative comparison of retinal ganglion cell axons to optic nerve crush in neonate and adult mice. Dev. Brain Res. 16:231-240.
2. Arakawa, Y., M. Sendtner, and H. Thoenen. 1990. Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in culture: comparison with other neurotrophic factors and cytokines. J. Neurosci. 10: 3507-3515.
3. Armstrong, J. F., M. H. Kaufman, D. J. Harrison, and A. R. Clark. 1995. High-frequency developmental abnormalities in p53-deficient mice. Curr. Biol. 5:931-936.
4. Baker, S. J., S. Markowitz, E. R. Fearon, J. K. V. Willson, and B. Vogelstein. 1990. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912-915.
5. Barres, B. A., I. K. Hart, H. S. Coles, J. F. Burne, J. T. Voyvodic, W. D. Richardson, and M. C. Raff. 1992. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70:31-46.
6. Barres, B. A., M. C. Raff, F. Gaese, I. Bartke, G. Dechant, and Y. A. Barde. 1994. A crucial role for neurotrophin-3 in oligodendrocyte development. Nature (London) 367:371-375.
7. Barres, B. A., R. Schmid, M. Sendtner, and M. C. Raff. 1993. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118:283-295.
8. Bottenstein, J. E., and G. H. Sato. 1979. Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc. Natl. Acad. Sci. USA 76: 514-517.
9. Bottenstein, J. E., and G. H. Sato (ed.). 1985. Cell culture in the neurosciences, p. 3-44. Plenum Press, New York.
10. Buchman, V. L., and A. M. Davies. 1993. Different neurotrophins are expressed and act in a developmental sequence to promote the survival of embryonic sensory neurons. Development 118:989-1001.
11. Gaelles, C., A. Helmberg, and M. Karin. 1994. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature (London) 370:220-223.
12. Chen, P.-L., Y. Chen, R. Bookstein, and W.-H. Lee. 1990. Genetic mechanisms of tumor suppression by the human p53 gene. Science 259:1576-1580.
13. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
14. Cowan, W. M. 1973. Neuronal death as a regulative mechanism in the control of cell number in the nervous system, p. 19-41. In M. Rockstein (ed.), Development and aging of the nervous system. Academic Press, New York.
15. Cowan, W. M., J. W. Fawcett, D. D. O'Leary, and B. B. Stanfield. 1984. Regressive events in neurogenesis. Science 225:1258-1265.
16. Diller, L., J. Kassel, C. E. Nelson, M. A. Gryka, G. Litwak, M. Gebhardt, B. Bressac, M. Ozturk, S. J. Baker, B. Vogelstein, and S. H. Friend. 1990. p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell. Biol. 10:5772-5781.
17. Donehower, L. A., and A. Bradley. 1993. The tumor suppressor p53. Biochim. Biophys. Acta 1155:181-205.
18. Dugalczyk, A., J. A. Haron, E. M. Stone, O. E. Dennison, K. N. Rothblum, and R. J. Schwartz. 1983. Cloning and sequencing of a deoxyribonucleic acid copy of glyceraldehyde-3-phosphate dehydrogenase messenger ribonucleic acid isolated from chicken muscle. Biochemistry 22:1605-1613.
19. Duguid, J. R., C. W. Bohmot, N. Liu, and W. W. Tourtellotte. 1989. Changes in brain gene expression shared by scrapie and Alzheimer disease. Proc. Natl. Acad. Sci. USA 86:7260-7264.
20. Eizenberg, O., A. Faber-Elman, E. Gottlieb, M. Oren, V. Rotter, and M. Schwartz. 1995. Direct involvement of p53 in programmed cell death of oligodendrocytes. EMBO J. 14:1136-1144.
21. Erlich, H. A. 1989. PCR technology: principles and applications for DNA amplification. Stockton Press, New York.
22. Feinberg, A., and B. Vogelstein. 1984. A technique for radiolabeling restriction endonuclease fragments to high specific activity. Anal. Biochem. 137: 266-267.
23. Feinstein, E., R. P. Gale, J. Reed, and E. Canaani. 1992. Expression of the normal p53 gene induces differentiation of K562 cells. Oncogene 7:1853-1857.
24. Ferrer, I., A. Tortosa, E. Condom, R. Blanco, A. Macaya, and A. Planas. 1994. Increased expression of bcl-2 immunoreactivity in the developing cerebral cortex of the rat. Neurosci. Lett. 179:13-16.
25. Gannon, J. V., and D. P. Lane. 1991. Protein synthesis required to anchor a mutant p53 protein which is temperature-sensitive for nuclear transport. Nature (London) 349:802-806.
26. Garcia-Valenzuela, E., W. Gorczyca, Z. Darzynkiewicz, and S. C. Sherma. 1994. Apoptosis in adult retinal ganglion cells after axotomy. J. Neurobiol. 25:431-438.
27. Ginsberg, D., D. Michael-Michalovitz, D. Ginsberg, and M. Oren. 1991. Induction of growth arrest by a temperature-sensitive p53 mutant is correlated with increased nuclear localization and decreased stability of the protein. Mol. Cell. Biol. 11:582-585.
28. Goslin, K., and G. Banker. 1991. Rat hippocampal neurons in low density culture, p. 251-281. In G. Banker and K. Goslin (ed.), Culturing nerve cells. MIT Press, Cambridge, Mass.
29. Gottlieb, E., R. Haffner, T. von Ruden, E. W. Wagner, and M. Oren. 1994. Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal. EMBO J. 13: 1368-1374.
30. Grafstein, B., and N. A. Ingoglia. 1982. Intracranial transection of the optic nerve in adult mice: preliminary observations. Exp. Neurol. 76:318-330.
31. Harlow, E., L. V. Crawford, D. C. Pim, and N. M. Williamson. 1981. Monoclonal antibodies specific for simian virus 40 antigens. J. Virol. 39:861-869.
32. Hartwell, L. 1992. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71:543-546.
33. Hartwell, L. H., and T. A. Weinert. 1989. Checkpoints: controls that ensure the order of cell cycle events. Science 246:629-633.
34. Haupt, Y., S. Rowan, E. Shaulian, K. H. Vousden, and M. Oren. 1995. Induction of apoptosis in HeLa cells by transactivation-deficient p53. Genes Dev. 9:2170-2183.
35. Johnson, G. D., R. S. Davidson, K. C. McNamee, D. G. Russell, and E. J. Holborow. 1982. Fading of immunofluorescence during microscopy: a study of the phenomenon and its remedy. J. Immunol. Methods 55:231-242.
36. Kane, D. J., T. A. Sarafin, R. Anton, H. Hahn, E. Butler-Gralla, V. J. Selverstone, T. Ord, and D. E. Bredesen. 1993. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262:1274-1277.
37. Kastan, M. B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R. W. Craig. 1991. Participation of p53 in the cellular response to DNA damage. Cancer Res. 51:6304-6311.
38. Korsmeyer, S. J., J. R. Shutter, D. J. Veis, D. E. Merry, and Z. N. Oltvai. 1993. Bcl-2/bax: a rheostat that regulates an antioxidant pathway and cell death. Semin. Cancer Biol. 4:327-332.
39. Krajewski, S., J. K. Mai, M. Krajewska, M. Sikorska, M. J. Mossakowski, and J. C. Reed. 1995. Upregulation of bax protein levels in neurons following cerebral ischemia. J. Neurosci. 15:6364-6376.
40. Lane, D. P. 1992. Worrying about p53. Curr. Biol. 2:581-583.
41. Lehrach, H., D. Diamond, J. M. Wosney, and H. Boedtker. 1977. RNA molecular weight determination by gel electrophoresis under denaturing conditions: a critical reexamination. Biochemistry 16:4743-4751.
42. Livingstone, L. R., A. White, J. Sprouse, E. Livanson, T. Jacks, and T. D. Tisty. 1992. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923-935.
43. Louis, J.-C., E. Magal, S. Takayama, and S. Varon. 1993. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science 259:689-692.
44. Mah, S. P., L. T. Zhong, Y. Liu, A. Roghani, R. H. Edwards, and D. E. Bredesen. 1993. The protooncogene bcl-2 inhibits apoptosis in PC12 cells. J. Neurochem. 60:1183-1186.
45. Maltzman, W., M. Oren, and A. J. Levine. 1981. The structural relationships between 54000-molecular weight cellular tumor antigens detected in viral-and nonviral-transformed cells. Virology 112:145-156.
46. Martínez, J., I. Georgoff, J. Martínez, and A. J. Levine. 1991. Cellular localization and cell cycle regulation by a temperature sensitive-mutant p53 protein. Genes Dev. 5:151-159.
47. McCarthy, K. D., and J. J. deVellis. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 85:890-902.
48. McKinnon, R. D., T. Matsui, M. Dubois-Dalcq, and S. A. Aaronson. 1990. FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 5:603-614.
49. Mercer, W. E., M. Amin, G. J. Sauve, E. Appella, S. J. Ullrich, and J. Romano. 1990. Wild-type p53 is antiproliferative in SV40-transformed hamster cells. Oncogene 5:973-980.
50. Mercer, W. E., M. T. Shields, M. Amin, G. J. Sauve, E. Appella, and S. J. Ullrich. 1990. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc. Natl. Acad. Sci. USA 87:6166-6170.
51. Merry, D. E., D. J. Veis, W. F. Hickey, and S. J. Korsmeyer. 1994. Bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development 120:301-311.
52. Michalovitz, D., O. Halevy, and M. Oren. 1990. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62:671-680.
53. Misantone, L. J., M. Gershenbaum, and M. Murray. 1984. Viability of retinal ganglion cells after optic nerve crush in rats. J. Neurocytol. 13:449-465.
54. Miyashita, T., S. Krajewski, M. Krajewska, H. G. Wang, H. K. Lin, D. A. Liebermann, B. Hoffman, and J. C. Reed. 1994. Tumor suppressor p53 is a regulator of bcl-2 and bax in gene expression in vitro and in vivo. Oncogene 9:1799-1805.
55. Miyashita, T., and J. C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299.
56. Moll, U. M., M. LaQuaglia, J. Benard, and G. Riou. 1995. Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc. Natl. Acad. Sci. USA 92:4407-4411.
57. Moll, U. M., G. Riou, and A. J. Levine. 1992. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc. Natl. Acad. Sci. USA 89:7262-7266.
58. Noble, M., K. Murray, P. Strobant, M. D. Waterfield, and P. Riddle. 1988. Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature (London) 333:560-562.
59. Oltvai, Z. N., C. L. Milliman, and S. J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74:609-619.
60. Oppenhaim, R. W. 1981. Neuronal cell death and some related regressive phenomena during neurogenesis: a selective historical review and progress report, p. 74-133. In W. M. Cowan (ed.), Studies in developmental neurobiology: essays in honor of Victor Hamburger. Oxford University Press, New York.
61. Oppenhaim, R. W. 1991. Cell death during development of the nervous system. Annu. Rev. Neurosci. 14:453-501.
62. Quigley, H. A., R. W. Nickells, L. A. Kerrigan, M. E. Pease, D. J. Thibault, and D. J. Zack. 1995. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest. Ophthalmol. Visual Sci. 36: 774-786.
63. Raff, M. C., B. A. Barres, J. F. Burne, H. S. Coles, Y. Ishizaki, and M. D. Jacobson. 1993. Programmed cell death and the control of cell survival: lessons from the nervous system. Science 262:695-700.
64. Raff, M. C., R. H. Miller, and M. Noble. 1983. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature (London) 303:390-396.
65. Reed, M., Y. Wang, G. Mayr, M. E. Anderson, J. F. Schwedes, and P. Tegtmeyer. 1993. p53 domains: suppression, transformation, and transactivation. Gene Expr. 3:95-107.
66. Richardson, W. D., N. Pringle, M. J. Mosley, B. Watermark, and M. Dubois-Dalcq. 1988. A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell 53:309-319.
67. Rodríguez, M., B. W. Scheithauer, G. Faites, and P. J. Kelly. 1993. Oligodendrocyte injury is an early event in lesions of multiple sclerosis. Mayo Clin. Proc. 68:627-636.
68. Sah, V. P., L. D. Attardi, G. J. Mulligan, B. O. Williams, R. T. Bronson, and T. Jacks. 1995. A subset of p53-deficient embryos exhibit exencephaly. Nat. Genet. 19:175-180.
69. Sakhi, S., A. Brace, N. Sun, G. Tocco, M. Baudry, and S. S. Schreiber. 1994. p53 induction is associated with neuronal damage in the central nervous system. Proc. Natl. Acad. Sci. USA 91:7525-7529.
70. Selvakumaran, M., H.-K. Lin, T. Miyashita, H. G. Wang, S. Krajewski, J. C. Reed, B. Hoffman, and D. Liebermann. 1994. Immediate early up-regulation of bax expression by p53 but not TGF-β1: a paradigm for distinct apoptotic pathways. Oncogene 9:1791-1798.
71. Shaulian, E., A. Zauberman, D. Ginsberg, and M. Oren. 1992. Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol. Cell. Biol. 12:5581-5592.
72. Shaulsky, G., A. Ben-Ze'ev, and V. Rotter. 1990. Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells. Oncogene 5:1707-1711.
73. Shaulsky, G., N. Goldfinger, A. Ben-Ze'ev, and V. Rotter. 1990. Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis. Mol. Cell. Biol. 10:6565-6577.
74. Shaulsky, G., N. Goldfinger, A. Peled, and V. Rotter. 1991. Involvement of wild-type p53 in pre-B-cell differentiation in vitro. Proc. Natl. Acad. Sci. USA 88:8982-3986.
75. Shaulsky, G., N. Goldfinger, M. S. Tosky, A. J. Levine, and V. Rotter. 1991. Nuclear localization is essential for the activity of p53 protein. Oncogene 6:2055-2065.
76. Shaw, P., R. Bovey, S. Tardy, R. Sahli, B. Sordat, and J. Costa. 1992. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA 89:4495-4499.
77. Temple, S., and M. C. Raf. 1986. Clonal analysis of oligodendrocyte development in culture: evidence for a developmental clock that counts cell divisions. Cell 44:773-779.
78. Vantini, G., and S. D. Skaper. 1992. Neurotrophic factors: from physiology to pharmacology? Pharmacol. Res. 26:1-15.
79. waf1/cip1. Genes Dev. 8:2817-2830.
80. Yonish-Rouach, E., D. Ginsberg, and M. Oren. 1993. The role of tumor suppressor genes in apoptosis, p. 187-202. In M. Lavin and D. Watters (ed.), Programmed cell death. Harwood, Chur, Switzerland.
81. Yonish-Rouach, E., D. Resnitzky, J. Lotem, L. Sachs, A. Kimchi, and M. Oren. 1991. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature (London) 352:345-347.
82. Zhong, L.-T., T. Sarafian, D. J. Kane, A. C. Charles, S. P. Mah, R. H. Edwards, and D. E. Bredesen. 1993. Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc. Natl. Acad. Sci. USA 90:4533-4537.